These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16620633)

  • 1. [Development of drugs with antiherpetic activity].
    Lin JW; Chen QM; Zhou HM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jan; 41(1):60-2. PubMed ID: 16620633
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxicologic research on the antiherpetic preparation viracin and its effect on fetal development].
    Boiadzhieva N
    Akush Ginekol (Sofiia); 1988; 27(5):8-11. PubMed ID: 2851943
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
    Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
    Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay between antiviral activity, oligonucleotide hybridisation and nucleic acids incorporation studies.
    Herdewijn P
    Antiviral Res; 2006 Sep; 71(2-3):317-21. PubMed ID: 16690140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds.
    Artemenko AG; Muratov EN; Kuz'min VE; Kovdienko NA; Hromov AI; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
    J Antimicrob Chemother; 2007 Jul; 60(1):68-77. PubMed ID: 17550890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of activity, synthesis and biological testing of anti-HSV active peptides.
    Jenssen H; Gutteberg TJ; Rekdal Ø; Lejon T
    Chem Biol Drug Des; 2006 Jul; 68(1):58-66. PubMed ID: 16923027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in antiherpetic drugs.
    Flowers FP; Araujo OE; Turner LA
    Int J Dermatol; 1988 Nov; 27(9):612-6. PubMed ID: 2852644
    [No Abstract]   [Full Text] [Related]  

  • 8. Retinoic acid analogues inhibit human herpesvirus 8 replication.
    Caselli E; Galvan M; Santoni F; Alvarez S; de Lera AR; Ivanova D; Gronemeyer H; Caruso A; Guidoboni M; Cassai E; Dolcetti R; Di Luca D
    Antivir Ther; 2008; 13(2):199-209. PubMed ID: 18505171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research on a substance with antiviral activity. XXI. Preparation and antiherpes activity of 2-acylamino-3,5-dichloropyridine].
    Garuti L; Ferranti A; Giovanninetti G; Baserga M; Mannini Palenzona A
    Farmaco Sci; 1981 Oct; 36(10):862-6. PubMed ID: 6273214
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on the development of drugs against smallpox.
    Tse-Dinh YC
    Curr Opin Investig Drugs; 2008 Aug; 9(8):865-70. PubMed ID: 18666034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on antiviral resistance.
    Griffiths PD
    J Clin Virol; 2009 Sep; 46(1):3-8. PubMed ID: 19615937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First demonstration of the effectiveness of inhibitors of cellular protein kinases in antiviral therapy.
    Schang LM
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):953-6. PubMed ID: 17181411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral agents. Part 25: 2-(polysubstituted benzoylamino)-3,5-dichloro-pyridines with antiherpetic activity.
    Ferranti A; Roberti M; Garuti L; Giovanninetti G; Palenzona AM
    Pharmazie; 1988 May; 43(5):359-60. PubMed ID: 2845452
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture.
    Reichling J; Neuner A; Sharaf M; Harkenthal M; Schnitzler P
    Pharmazie; 2009 Aug; 64(8):538-41. PubMed ID: 19746844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design of drugs for HIV and HCV.
    De Clercq E
    Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of nucleoside-based antiviral drugs in ionic liquids.
    Kumar V; Malhotra SV
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5640-2. PubMed ID: 18796352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotides as antivirals: dream or realistic perspective?
    Van Aerschot A
    Antiviral Res; 2006 Sep; 71(2-3):307-16. PubMed ID: 16621039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches for the development of antiviral compounds: the case of hepatitis C virus.
    Schinazi RF; Coats SJ; Bassit LC; Lennerstrand J; Nettles JH; Hurwitz SJ
    Handb Exp Pharmacol; 2009; (189):25-51. PubMed ID: 19048196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition.
    Schnute ME; Brideau RJ; Collier SA; Cudahy MM; Hopkins TA; Knechtel ML; Oien NL; Sackett RS; Scott A; Stephan ML; Wathen MW; Wieber JL
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3856-9. PubMed ID: 18595689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broccoli compound inhibits HSV.
    AIDS Patient Care STDS; 2003 Nov; 17(11):609. PubMed ID: 14748359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.